Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026909 · ClinicalTrials.gov registry record · NA
Intraarticular Corticosteroid Therapy in Perthes Disease.
A NA study, sponsored by Seattle Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01026909 is a NA study that was terminated before completion, run by Seattle Children's Hospital. The registered enrollment target is 3 participants.
The verdict
NCT01026909, a NA study, was terminated before completion, sponsored by Seattle Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Legg-Calve-Perthes disease (LCP) represents the loss of blood flow to the head of the femur, resulting in significant hip pain and potential long term disability. This study represents a single center, randomized, prospective, controlled study comparing the treatment of LCP with an intraarticular corticosteroid (triamcinolone hexacetonide) injection with traditional nonoperative treatment.
Interventions
- DRUG Aristospan 20mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01026909
The ClinicalTrials.gov registry entry for NCT01026909 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aristospan 20mg is the first listed.
NCT01026909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01026909 about?
NCT01026909 is a clinical study titled "Intraarticular Corticosteroid Therapy in Perthes Disease.". Legg-Calve-Perthes disease (LCP) represents the loss of blood flow to the head of the femur, resulting in significant hip pain and potential long term disability. This study represents a single center, randomized, prospective, controlled study comparing the treatment of LCP with an intraarticular co...
What is the current status of trial NCT01026909?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2009-03. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01026909?
The interventions under investigation include: Aristospan 20mg (DRUG).
Who is sponsoring clinical trial NCT01026909?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.